PatriciaL.LugarMD
Internal Medicine • Durham, NCAllergy & Immunology
Associate Professor, Medicine, Duke University School of Medicine
Dr. Lugar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-684-8111
Summary
- Associate Professor at Duke University in the Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine. My schedule is split between clinical care, clinical trials and translational research. I focus on rare disorders primarily immune deficiency. My research is aimed at improving diagnostics, therapeutics, and quality of life for patients with immune deficiency.
Education & Training
NIH Clinical CenterPost-Doctoral Fellowship, 2005 - 2007- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2003 - 2005
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1999 - 2002
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1999
SUNYAB, Roswell Park Cancer InstituteMS, Molecular Medicine, 1996 - 1998
Certifications & Licensure
NC State Medical License 2007 - 2025
DC State Medical License 2002 - 2008
MD State Medical License 2003 - 2004
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants Start of enrollment: 2014 May 14
- Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE Start of enrollment: 2016 Mar 03
- Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE Start of enrollment: 2016 May 26
- Join now to see all
Publications & Presentations
PubMed
- Validation of Risk Factors for Early Mortality in Cartilage-Hair Hypoplasia.Svetlana Vakkilainen, Kira Ahonen, , , Outi Mäkitie
Journal of Clinical Immunology. 2024-04-27 - 41 citationsEfficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.Ana Maria Copaescu, Sara Vogrin, Fiona James, Kyra Y L Chua, Morgan T Rose
JAMA Internal Medicine. 2023-09-01 - Immunoglobulin Deficiency and the Unified Airway.Chadi A Makary, David W Jang, Patricia Lugar
Otolaryngologic Clinics of North America. 2023-02-01
Authored Content
- CME: Biologics in the Treatment of Adults With T2-High, Uncontrolled AsthmaMay 2020
- Women’s Health and Primary Immunodeficiency DiseasesJanuary 2020
- PI and Womens Health: A Focus on Pregnancy and BeyondJuly 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
